The Molecular Basis of Von Hippel-Lindau Disease
Open Access
- 1 May 1997
- journal article
- review article
- Published by Springer Nature in Molecular Medicine
- Vol. 3 (5) , 289-293
- https://doi.org/10.1007/bf03401807
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor geneKidney International, 1997
- Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau ProteinPublished by Elsevier ,1996
- Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeHuman Genetics, 1996
- Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinomaHuman Molecular Genetics, 1994
- Identification of intragenic mutations in the Von Hippel — Lindau disease tumour suppressor gene andcorrelation with disease phenotypeHuman Molecular Genetics, 1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.Journal of Medical Genetics, 1990